Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

Nucleic Acids Research

Volumn 38, Issue 17, 2010, Pages 5884-5892

  Anderson, Bart R ^a   Muramatsu, Hiromi ^a   Nallagatla, Subba R ^b   Bevilacqua, Philip C ^b   Sansing, Lauren H ^a   Weissman, Drew ^a   Karikó, Katalin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 2ALPHA; MESSENGER RNA; PROTEIN KINASE R; PSEUDOURIDINE; URIDINE;

ARTICLE; CELL STRAIN HEK293; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; RNA TRANSLATION; TRANSLATION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL LINE; CHEMISTRY; METABOLISM; MOUSE; PROTEIN SYNTHESIS;

ANIMALS; CELL LINE; CELLS, CULTURED; EIF-2 KINASE; HUMANS; MICE; PROTEIN BIOSYNTHESIS; PSEUDOURIDINE; RNA, MESSENGER;

EID: 77957242130     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq347     Document Type: Article

References (55)

1. Weissman,D., Ni,H., Scales,D., Dude,A., Capodici,J., McGibney,K., Abdool,A., Isaacs,S.N., Cannon,G. and Karikó,K. (2000) HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J. Immunol., 165, 4710-4717.
2. Nienhuis,A.W., Dunbar,C.E. and Sorrentino,B.P. (2006) Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther., 13, 1031-1049.
3. Donsante,A., Miller,D.G., Li,Y., Vogler,C., Brunt,E.M., Russell,D.W. and Sands,M.S. (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science, 317, 477.
4. Karikó K., Buckstein,M., Ni,H. and Weissman,D. (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity, 23, 165-175.
5. Hornung,V., Ellegast,J., Kim,S., Brzozka,K., Jung,A., Kato,H., Poeck,H., Akira,S., Conzelmann,K.-K., Schlee,M. et al. (2006) 50-Triphosphate RNA is the ligand for RIG-I. Science, 314, 994-997.
6. Hunt,T. and Ehrenfeld,E. (1971) Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nature New Biol., 230, 91-94.
7. Ehrenfeld,E. and Hunt,T. (1971) Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc. Natl Acad. Sci. U.S.A., 68, 1075-1078.
8. Minks,M.A., West,D.K., Benvin,S. and Baglioni,C. (1979) Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem., 254, 10180-10183.
9. Hunter,T., Hunt,T., Jackson,R.J. and Robertson,H.D. (1975) The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J. Biol. Chem., 250, 409-417.
10. Bevilacqua,P.C., George,C.X., Samuel,C.E. and Cech,T.R. (1998) Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry, 37, 6303-6316.
11. Zheng,X. and Bevilacqua,P.C. (2004) Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA, 10, 1934-1945.
12. Nallagatla,S.R., Hwang,J., Toroney,R., Zheng,X., Cameron,C.E. and Bevilacqua,P.C. (2007) 5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science, 318, 1455-1458.
13. Dauber,B., Martinez-Sobrido,L., Schneider,J., Hai,R., Waibler,Z., Kalinke,U., Garcia-Sastre,A. and Wolff,T. (2009) Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog., 5, e1000473.
14. Kaempfer,R. (2003) RNA sensors: novel regulators of gene expression. EMBO Rep., 4, 1043-1047.
15. Edery,I., Petryshyn,R. and Sonenberg,N. (1989) Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism. Cell, 56, 303-312.
16. SenGupta,D.N. and Silverman,R.H. (1989) Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res., 17, 969-978.
17. Davis,S. and Watson,J.C. (1996) In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3' untranslated regions of human alpha-tropomyosin. Proc. Natl Acad. Sci. U.S.A., 93, 508-513.
18. Tian,B., White,R.J., Xia,T., Welle,S., Turner,D.H., Mathews,M.B. and Thornton,C.A. (2000) Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA, 6, 79-87.
19. Ben-Asouli,Y., Banai,Y., Pel-Or,Y., Shir,A. and Kaempfer,R. (2002) Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell, 108, 221-232.
20. Nussbaum,J.M., Gunnery,S. and Mathews,M.B. (2002) The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR. Nucleic Acids Res., 30, 1205-1212.
21. Armstrong,M.E., Gantier,M., Li,L., Chung,W.Y., McCann,A., Baugh,J.A. and Donnelly,S.C. (2008) Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J. Immunol., 180, 7125-7133.
22. Sledz,C.A., Holko,M., de Veer,M.J., Silverman,R.H. and Williams,B.R. (2003) Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol., 5, 834-839.
23. Zhang,Z., Weinschenk,T., Guo,K. and Schluesener,H.J. (2006) siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J. Cell. Biochem., 97, 1217-1229.
24. Schlee,M., Hornung,V. and Hartmann,G. (2006) siRNA and isRNA: two edges of one sword. Mol. Ther., 14, 463.
25. Puthenveetil,S., Whitby,L., Ren,J., Kelnar,K., Krebs,J.F. and Beal,P.A. (2006) Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification. Nucleic Acids Res., 34, 4900-4911.
26. Gorina,R., Santalucia,T., Petegnief,V., Ejarque-Ortiz,A., Saura,J. and Planas,A.M. (2009) Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA. Glia, 57, 93-107.
27. Torrence,P.F. and Friedman,R.M. (1979) Are double-stranded RNA-directed inhibition of protein synthesis in interferon-treated cells and interferon induction related phenomena? J. Biol. Chem., 254, 1259-1267.
28. Minks,M., West,D., Benvin,S., Greene,J., Ts0o,P. and Baglioni,C. (1980) Activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells by 20-O-methylated poly (inosinic acid):poly(cytidylic acid). J. Biol. Chem., 255, 6403-6407.
29. Content,J., Lebleu,B. and De Clercq,E. (1978) Differential effects of various double-stranded RNAs on protein synthesis in rabbit reticulocyte lysates. Biochemistry, 17, 88-94.
30. Torrence,P.F., Johnston,M.I., Epstein,D.A., Jacobsen,H. and Friedman,R.M. (1981) Activation of human and mouse 2-5A synthetases and mouse protein P1 kinase by nucleic acids. Structure-activity relationships and correlations with inhibition of protein synthesis and interferon induction. FEBS Lett., 130, 291-296.
31. Puthenveetil,S., Veliz,E.A. and Beal,P.A. (2004) Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N2-benzylguanosine limits the binding sites occupied by PKR. Chembiochem, 5, 383-386.
32. Nallagatla,S.R. and Bevilacqua,P.C. (2008) Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA, 14, 1201-1213.
33. Kariko,K., Muramatsu,H., Welsh,F.A., Ludwig,J., Kato,H., Akira,S. and Weissman,D. (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther., 16, 1833-1840.
34. Romano,P.R., Garcia-Barrio,M.T., Zhang,X., Wang,Q., Taylor,D.R., Zhang,F., Herring,C., Mathews,M.B., Qin,J. and Hinnebusch,A.G. (1998) Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol. Cell. Biol., 18, 2282-2297.
35. Kawagishi-Kobayashi,M., Cao,C., Lu,J., Ozato,K. and Dever,T.E. (2000) Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology, 276, 424-434.
36. Kawagishi-Kobayashi,M., Silverman,J.B., Ung,T.L. and Dever,T.E. (1997) Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2alpha. Mol. Cell. Biol., 17, 4146-4158.
37. Cohen-Chalamish,S., Hasson,A., Weinberg,D., Namer,L.S., Banai,Y., Osman,F. and Kaempfer,R. (2009) Dynamic refolding of IFN-gamma mRNA enables it to function as PKR activator and translation template. Nat. Chem. Biol., 5, 896-903.
38. Karikó,K. and Weissman,D. (2007) Naturally-occurring nucleoside modifications suppress the immunostimulatory activity of RNA: Implication for therapeutic RNA development. Curr. Opin. Drug Discov. Devel., 10, 523-532.
39. Szer,W. and Ochoa,S. (1964) Complexing ability and coding properties of synthetic polynucleotides. J. Mol. Biol., 12, 823-834.
40. Ziomek,K., Kierzek,E., Biala,E. and Kierzek,R. (2002) The influence of various modified nucleotides placed as 3'-dangling end on thermal stability of RNA duplexes. Biophys. Chem., 97, 243-249.
41. Ziomek,K., Kierzek,E., Biala,E. and Kierzek,R. (2002) The thermal stability of RNA duplexes containing modified base pairs placed at internal and terminal positions of the oligoribonucleotides. Biophys. Chem., 97, 233-241.
42. Charette,M. and Gray,M.W. (2000) Pseudouridine in RNA: what, where, how, and why. IUBMB Life, 49, 341-351.
43. Kumar,R.K. and Davis,D.R. (1997) Synthesis and studies on the effect of 2-thiouridine and 4-thiouridine on sugar conformation and RNA duplex stability. Nucleic Acids Res., 25, 1272-1280.
44. Nair,T.M., Myszka,D.G. and Davis,D.R. (2000) Surface plasmon resonance kinetic studies of the HIV TAR RNA kissing hairpin complex and its stabilization by 2-thiouridine modification. Nucleic Acids Res., 28, 1935-1940.
45. Luyten,I. and Herdewijn,P. (1998) Hybridization properties of base-modified oligonucleotides within the double and triple helix motif. Eur. J. Med. Chem., 33, 515-576.
46. Kierzek,E. and Kierzek,R. (2003) The thermodynamic stability of RNA duplexes and hairpins containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines. Nucleic Acids Res., 31, 4472-4480.
47. Bevilacqua,P.C. and Cech,T.R. (1996) Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry, 35, 9983-9994.
48. Ryter,J.M. and Schultz,S.C. (1998) Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. EMBO J., 17, 7505-7513.
49. Robbins,M., Judge,A., Liang,L., McClintock,K., Yaworski,E. and Maclachlan,I. (2007) 2'-O-methyl-modified RNAs act as TLR7 antagonists. Mol. Ther., 15, 1663-1669.
50. Yu,D., Wang,D., Zhu,F.G., Bhagat,L., Dai,M., Kandimalla,E.R. and Agrawal,S. (2009) Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9. J. Med. Chem., 52, 5108-5114.
51. Wang,D., Bhagat,L., Yu,D., Zhu,F.G., Tang,J.X., Kandimalla,E.R. and Agrawal,S. (2009) Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9. J. Med. Chem., 52, 551-558.
52. Hamm,S., Latz,E., Hangel,D., Müller,T., Yu,P., Golenbock,D., Sparwasser,T., Wagner,H. and Bauer,S. (2009) Alternating 2'-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist. Immunobiology, In Press, doi:10.1016/j.imbio.2009.1009.1003.
53. Kirino,Y. and Mourelatos,Z. (2007) Mouse Piwi-interacting RNAs are 2'-O-methylated at their 3' termini. Nat. Struct. Mol. Biol., 14, 347-348.
54. Rozenski,J., Crain,P. and McCloskey,J. (1999) The RNA Modification Database: 1999 update. Nucleic Acids Res., 27, 196-197.
55. Prakash,T.P., Naik,N., Sioufi,N., Bhat,B. and Swayze,E.E. (2009) Activity of siRNAs with 2-thio-2'-O-methyluridine modification in mammalian cells. Nucleosides Nucleotides Nucleic Acids, 28, 902-910.